Sanofi (SNY) es una empresa que cotiza en bolsa en el Salud sector, operando dentro de la Drug Manufacturers - General industria. La empresa tiene su sede en Paris, France. El CEO actual es Olivier Charmeil.
SNY tiene fecha de IPO 2002-07-01, 82,878 empleados a tiempo completo, cotiza en el NASDAQ Global Select, una capitalización de mercado de $116.02B.
Sanofi is a Paris-based pharmaceutical and healthcare company that researches, develops, manufactures, and markets a comprehensive range of therapeutic solutions globally. The company operates through three primary segments: Pharmaceuticals, Vaccines, and Consumer Healthcare, offering specialty care products for conditions including multiple sclerosis, immunology, rare diseases, oncology, and diabetes, alongside a broad portfolio of pediatric and adult vaccines covering poliomyelitis, influenza, meningitis, and other endemic diseases. Sanofi also provides consumer health products spanning allergy relief, pain management, digestive wellness, and dermatological care. The company maintains strategic collaborations with leading institutions, including GlaxoSmithKline for COVID-19 vaccine development and Stanford University School of Medicine for immunology research, positioning itself as a diversified leader in both prescription pharmaceuticals and preventive healthcare.
